Moberg Pharma AB
SE0003613090
Annual Insiders Turnover, USD 2
2018 | 2019 | 2024 |
---|---|---|
98,006.44 | 1,329,455.16 | 146,076.52 |
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 31 Insiders: 11
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Mark Beveridge CFO |
29.09 SEK |
13,153 Sold |
382,626 SEK |
26/06/2024 | 25/06/2024 |
Anna Helena Constance Ljung CEO |
29.09 SEK |
13,153 Sold |
382,626 SEK |
26/06/2024 | 25/06/2024 |
Mark Beveridge CFO |
29.09 SEK |
13,153 Sold |
382,626 SEK |
26/06/2024 | 25/06/2024 |
Annika Christine Magnusson EX OFF |
29.09 SEK |
13,153 Sold |
382,626 SEK |
26/06/2024 | 25/06/2024 |
Annika Christine Magnusson DIR |
66.67 SEK |
6,227 Sold |
415,168 SEK |
29/06/2019 | 28/06/2019 |
Peter Wolpert DIR |
66.67 SEK |
75,000 Sold |
5,000,415 SEK |
02/07/2019 | 28/06/2019 |
Anna Helena Constance Ljung CEO |
66.67 SEK |
40,000 Sold |
2,666,888 SEK |
02/07/2019 | 28/06/2019 |
Annika Christine Magnusson DIR |
66.67 SEK |
15,000 Sold |
1,000,083 SEK |
29/06/2019 | 28/06/2019 |
Torbjörn Wärnheim VP |
66.67 SEK |
7,500 Sold |
500,042 SEK |
01/07/2019 | 28/06/2019 |
Torbjörn Wärnheim VP |
42.97 SEK |
7,500 Bought |
322,275 SEK |
01/07/2019 | 28/06/2019 |